1712438
Last Update Posted: 2021-01-19
Recruiting has ended
Males accepted | Under |
110 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Human Cell Line-derived Recombinant Factor VIII (Human-cl-rhFVIII) in Previously Untreated Patients
Investigate the inhibitor development rate of Human cl rhFVIII in previously untreated patients with severe Hemophilia A.
Eligibility
Relevant conditions:
Severe Hemophilia A
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the study if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov